PHASE I TRIAL OF CARBOPLATIN, BEVACIZUMAB, AND TEMSIROLIMUS IN ADVANCED SOLID TUMORS

被引：0
|
作者：
Westin, S. [1 ]
Castaneda, M. [2 ]
Pal, N. [1 ]
Urbauer, D. [3 ]
Janku, F. [2 ]
Wheler, J. [2 ]
Piha-Paul, S. [2 ]
Naing, A. [2 ]
Tsimberidou, A. [2 ]
Fu, S. [2 ]
Hong, D. [2 ]
Subbiah, V. [2 ]
Zinner, R. [2 ]
Karp, D. [2 ]
Coleman, R. [2 ]
Moulder, S. [2 ]
Kurzrock, R. [4 ]
机构：
[1] UT MD Anderson Canc Ctr, Gynecol Oncol & Reprod Med, Houston, TX USA
[2] UT MD Anderson Canc Ctr, Invest Canc Therapeut, Houston, TX USA
[3] UT MD Anderson Canc Ctr, Biostat, Houston, TX USA
[4] Univ Calif San Diego, Hematol & Oncol, Houston, TX USA
来源：
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER | 2015年 / 25卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
ESGO-0717
引用
收藏
页码：365 / 365
页数：1
相关论文
共 50 条
  • [31] A phase I study of ARQ 197 in combination with temsirolimus in advanced solid tumors.
    Kyriakopoulos, Christos
    Kolesar, Jill
    Eickhoff, Jens C.
    Heideman, Jennifer
    Liu, Glenn
    Wisinski, Kari Braun
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [32] Dual inhibition of VEGF pathway: Phase I trial of bevacizumab and cediranib in advanced solid tumors.
    Garrido-Laguna, I.
    Kurzrock, R.
    Wheler, J. J.
    Falchook, G. S.
    Piha-Paul, S. A.
    Fu, S.
    Naing, A.
    Hinojosa, C.
    Mistry, R.
    Scamardo, A.
    Culotta, K. S.
    Ekmekcioglu, S.
    Wen, S.
    Camacho, L. H.
    Ivy, S. P.
    Hong, D. S.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [33] A Phase I Study of Chloroquine with Carboplatin and Gemcitabine in Advanced Solid Tumors and NSCLC
    Karim, Nagla Abdel
    Bahassi, El Mustapha
    Khaled, Ahmed
    Shehata, Mahmoud
    Wise-Draper, Trisha
    O'Gara, Sue
    Morris, John
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S430 - S431
  • [34] Phase I study of temsirolimus (CCI-779), carboplatin, and paclitaxel in patients (pts) with advanced solid tumors: NCIC CTG IND 179
    Oza, A. M.
    Kollmannsberger, C.
    Hirte, H.
    Welch, S.
    Siu, L.
    Mazurka, J.
    Sederias, J.
    Doyle, L. A.
    Eisenhauer, E.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [35] Phase I study of temsirolimus in combination with EKB-569 in patients with advanced solid tumors
    Alan H. Bryce
    Ravi Rao
    Jann Sarkaria
    Joel M. Reid
    Yingwei Qi
    Rui Qin
    C. David James
    Robert B. Jenkins
    Joseph Boni
    Charles Erlichman
    Paul Haluska
    Investigational New Drugs, 2012, 30 : 1934 - 1941
  • [36] Phase I study of temsirolimus in combination with EKB-569 in patients with advanced solid tumors
    Bryce, Alan H.
    Rao, Ravi
    Sarkaria, Jann
    Reid, Joel M.
    Qi, Yingwei
    Qin, Rui
    James, C. David
    Jenkins, Robert B.
    Boni, Joseph
    Erlichman, Charles
    Haluska, Paul
    INVESTIGATIONAL NEW DRUGS, 2012, 30 (05) : 1934 - 1941
  • [37] Combination chemotherapy of carboplatin and gemcitabine against solid tumors: A phase I trial
    Tassinari D.
    Drudi G.
    Panzini I.
    Pasini G.
    Arcangeli V.
    Fochessati F.
    Gianni L.
    Mianulli A.M.
    Oliverio G.
    Pasquini E.
    Sartori S.
    Ravaioli A.
    International Journal of Clinical Oncology, 2001, 6 (6) : 279 - 283
  • [38] Phase I study of capecitabine, oxaliplatin, bevacizumab, and everolimus in advanced solid tumors
    Rangwala, Fatima
    Bendell, Johanna C.
    Kozloff, Mark F.
    Arrowood, Christy C.
    Dellinger, Andrew
    Meadows, Jennifer
    Tourt-Uhlig, Sandra
    Murphy, Jennifer
    Meadows, Kellen L.
    Starr, Aijing
    Broderick, Samuel
    Brady, John C.
    Cushman, Stephanie M.
    Morse, Michael A.
    Uronis, Hope E.
    Hsu, S. David
    Zafar, S. Yousuf
    Wallace, James
    Starodub, Alexander N.
    Strickler, John H.
    Pang, Herbert
    Nixon, Andrew B.
    Hurwitz, Herbert I.
    INVESTIGATIONAL NEW DRUGS, 2014, 32 (04) : 700 - 709
  • [39] Phase I study of cetuximab, erlotinib, and bevacizumab in patients with advanced solid tumors
    Lin, Chia-Chi
    Calvo, Emiliano
    Papadopoulos, Kyriakos P.
    Patnaik, Amita
    Sarantopoulos, John
    Mita, Alain C.
    Preston, Glenn G.
    Mita, Monica M.
    Rodon, Jordi
    Mays, Theresa
    Yeh, I-Tien
    O'Rourke, Pat
    Takimoto, Chris H.
    Dancey, Janet E.
    Chen, Helen
    Tolcher, Anthony W.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2009, 63 (06) : 1065 - 1071
  • [40] Phase I study of cetuximab, erlotinib, and bevacizumab in patients with advanced solid tumors
    Chia-Chi Lin
    Emiliano Calvo
    Kyriakos P. Papadopoulos
    Amita Patnaik
    John Sarantopoulos
    Alain C. Mita
    Glenn G. Preston
    Monica M. Mita
    Jordi Rodon
    Theresa Mays
    I-Tien Yeh
    Pat O’Rourke
    Chris H. Takimoto
    Janet E. Dancey
    Helen Chen
    Anthony W. Tolcher
    Cancer Chemotherapy and Pharmacology, 2009, 63 : 1065 - 1071
12345